CN113234724B - dsRNA (double-stranded ribonucleic acid) for preventing and treating termites and application thereof - Google Patents
dsRNA (double-stranded ribonucleic acid) for preventing and treating termites and application thereof Download PDFInfo
- Publication number
- CN113234724B CN113234724B CN202110538502.XA CN202110538502A CN113234724B CN 113234724 B CN113234724 B CN 113234724B CN 202110538502 A CN202110538502 A CN 202110538502A CN 113234724 B CN113234724 B CN 113234724B
- Authority
- CN
- China
- Prior art keywords
- dsrna
- termites
- termite
- template dna
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000256602 Isoptera Species 0.000 title claims abstract description 113
- 229920002477 rna polymer Polymers 0.000 title abstract description 4
- 238000000034 method Methods 0.000 claims abstract description 16
- 230000033001 locomotion Effects 0.000 claims abstract description 13
- 230000002431 foraging effect Effects 0.000 claims abstract description 11
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 13
- 239000002773 nucleotide Substances 0.000 claims description 12
- 125000003729 nucleotide group Chemical group 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 10
- 230000002452 interceptive effect Effects 0.000 claims description 7
- 230000002194 synthesizing effect Effects 0.000 claims description 4
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims 11
- 241000866536 Odontotermes formosanus Species 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 11
- 238000005516 engineering process Methods 0.000 abstract description 9
- 108090000623 proteins and genes Proteins 0.000 abstract description 9
- 238000013461 design Methods 0.000 abstract description 5
- 230000002265 prevention Effects 0.000 abstract description 5
- 108091030071 RNAI Proteins 0.000 abstract description 4
- 239000002299 complementary DNA Substances 0.000 abstract description 4
- 230000009368 gene silencing by RNA Effects 0.000 abstract description 4
- 108091036078 conserved sequence Proteins 0.000 abstract description 2
- 230000006698 induction Effects 0.000 abstract description 2
- 230000007246 mechanism Effects 0.000 abstract description 2
- 101150078024 CRY2 gene Proteins 0.000 description 37
- 108020004414 DNA Proteins 0.000 description 29
- 230000015572 biosynthetic process Effects 0.000 description 16
- 238000003786 synthesis reaction Methods 0.000 description 16
- 238000012360 testing method Methods 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000012634 fragment Substances 0.000 description 9
- 230000014509 gene expression Effects 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 238000010367 cloning Methods 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- 238000000137 annealing Methods 0.000 description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000012257 pre-denaturation Methods 0.000 description 4
- 238000004153 renaturation Methods 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 2
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 2
- 239000012880 LB liquid culture medium Substances 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000242873 Scopolia Species 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 241000383197 Cooperia punctata Species 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000010806 PrimeScriptTM RT Reagent kit Methods 0.000 description 1
- 241000196250 Prototheca Species 0.000 description 1
- 238000001793 Wilcoxon signed-rank test Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000021191 food habits Nutrition 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 230000005358 geomagnetic field Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006742 locomotor activity Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/05—Animals modified by non-integrating nucleic acids, e.g. antisense, RNAi, morpholino, episomal vector, for non-therapeutic purpose
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/70—Invertebrates
- A01K2227/706—Insects, e.g. Drosophila melanogaster, medfly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Environmental Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses dsRNA (double-stranded ribonucleic acid) for preventing and treating termites and application thereof, and relates to the technical field of biology; the invention designs dsRNA for preventing and controlling termites based on the conserved sequence of cDNA of blue light receptor Cry2 genes of odontotermes formosanus and odontotermes formosanus, wherein the dsRNA is dsRNA-1 or dsRNA-2; wherein the dsRNA-1 consists of a sequence as shown in SEQ ID NO: 10 is transcribed; the dsRNA-2 consists of a sequence shown as SEQ ID NO: 13 is transcribed; according to the termite control method, the key genes in a termite magnetic induction mechanism are blocked, so that the magnetic orientation behavior of the termites disappears, and the movement turning angle is also obviously increased, so that the foraging orientation and the homing capability of the termites are interfered, and the effect of controlling the termites is finally achieved. The invention can be applied to the prevention and treatment of termites by the RNAi technology, and the prevention and treatment technology has the characteristics of strong specificity, excellent effect and the like for preventing and treating the termites.
Description
Technical Field
The invention relates to the field of biotechnology, in particular to dsRNA (double-stranded ribonucleic acid) for preventing and treating termites and application thereof.
Background
Termites feed on various celluloses, and are one of insects which can efficiently degrade lignocellulose in natural environment. Termite has wide food habits, and the harm of the termite relates to various aspects closely related to human life, such as agriculture, forestry, water conservancy, transportation, house construction and the like. Termites have long been controlled by various methods including liquid poisoning, powder poisoning, nest digging, bait trapping, and light trapping. Although the above methods have some effects in termite control, the current chemical control methods relied upon can severely damage the ecological environment and threaten human health safety. Therefore, the development of new techniques and methods for termite control has become an urgent need in the field of termite control.
Termites living in a concealed environment can go out to forage and return to nests orderly. After the termites are out for foraging, the termites must return to the nest to provide food for other grades, and the accurate out-foraging and homing capacity of the termites is important for the survival of the whole nest group (see Animal identification, 2020, 23: 1051-.
Accordingly, based on the research and problems in the prior art, it is necessary to provide a new technology capable of controlling termites, and there is no report on controlling termite damage by interfering with the foraging orientation and homing ability of termites.
Disclosure of Invention
The invention aims to provide dsRNA for controlling termites and application thereof, so as to solve the problems in the prior art.
In order to achieve the above objects, the present invention provides a dsRNA for controlling termites, which is dsRNA-1 or dsRNA-2; wherein the dsRNA-1 consists of a sequence as shown in SEQ ID NO: 10 is transcribed; the dsRNA-2 consists of a sequence shown as SEQ ID NO: 13 is transcribed.
The invention also provides a template DNA for synthesizing the dsRNA-1 or dsRNA-2, wherein the nucleotide sequence of the template DNA of the dsRNA-1 is shown as SEQ ID NO: 10 is shown in the figure; the nucleotide sequence of the template DNA of the dsRNA-2 is shown as SEQ ID NO: shown at 13.
The invention also provides a use of said dsRNA or said template DNA, said use comprising any one of:
(1) the dsRNA or the template DNA is applied to the prevention and the treatment of termites;
(2) the dsRNA or the template DNA is applied to the preparation of a termite control product;
(3) the dsRNA or the template DNA is applied to the interference of termite magnetic orientation behavior;
(4) the dsRNA or the template DNA is applied to the preparation of a product interfering the magnetic directional behavior of the termites;
(5) the dsRNA or the template DNA is applied to interfere the foraging orientation and the homing capability of the termites;
(6) the dsRNA or the template DNA is applied to the preparation of a product for interfering the foraging orientation and the homing ability of the termites;
(7) the use of said dsRNA or said template DNA for reducing termite motion turning;
(8) the dsRNA or the template DNA is applied to the preparation of a product for reducing the movement turning angle of termites.
The invention also provides a method for preventing and controlling termites, interfering with the magnetic directional behavior of the termites, interfering with the foraging orientation and the homing capacity of the termites or increasing the movement turning angle of the termites, which comprises the following steps: introducing the dsRNA into the termite body.
The invention discloses the following technical effects:
the invention designs dsRNA based on the conserved sequences of cDNA of blue light receptor Cry2 genes of odontotermes formosanus and odontotermes formosanus, and can effectively inhibit the expression quantity of the Cry2 genes of the termites through RNAi technology. According to the termite control method, the key genes in a termite magnetic induction mechanism are blocked, so that the magnetic orientation behavior of the termites disappears, and the movement turning angle is also obviously increased, so that the magnetic orientation behavior and the movement capability of the termites are interfered, the foraging orientation and the homing capability of the termites are damaged, and the effect of controlling the termites is finally achieved. The invention can be applied to the prevention and treatment of termites by the RNAi technology, and the prevention and treatment technology has the characteristics of strong specificity, excellent effect, environmental friendliness and the like.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings needed to be used in the embodiments will be briefly described below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and it is obvious for those skilled in the art to obtain other drawings without inventive exercise.
FIG. 1 shows the effect of dsRNA injection on the expression level of Cry2 gene in odontotermes formosanus (A) and odontotermes formosanus (B) respectively; wherein, the termites injected with dsGFP are used as a control group, and the termites injected with dsCry2 are used as a treatment group; beta-actin and NADH are used as reference genes; bar graph data mean ± standard deviation, denotes P < 0.01;
FIG. 2 is a graph of the effect of dsRNA injection on the magnetic alignment behavior of odontotermes formosanus (A, B) and odontotermes formosanus (C, D), respectively; wherein, the termites injected with dsCry2 are treated group (A, C), and the termites injected with dsGFP are control group (B, D); dots represent the average orientation vector for each termite, arrows represent the average orientation vector for all tested termites, P <0.05 indicates orientation preference;
FIG. 3 is a graph of the effect of dsRNA injection on locomotor activity in odontotermes formosanus (A) and odontotermes formosanus (B); wherein, the termites injected with dsCry2 are treated groups, and the termites injected with dsGFP are control groups; data are mean ± standard deviation, P <0.05, P < 0.01.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
In order to make the aforementioned objects, features and advantages of the present invention comprehensible, embodiments accompanied with figures are described in further detail below.
Example 1 cloning of Termite Black wing Cry2 Gene sequence
1.1 design of specific primers for Cry2 Gene amplification
Searching is carried out from a transcriptome database of the odontotermes formosanus, and then sequence alignment is carried out by using NCBI Nucleotide-BLAST, so as to determine that 1 termite Cry2 gene fragment is obtained. From the Cry2 gene fragment obtained by the search, the following specific primers were designed online using NCBI Primer-BLAST:
3' Gene-specific primers: TCGCCCTAAAATGACACCTC (SEQ ID NO: 2);
5' Gene-specific primers: CATTATGAACGCGGGAAGCAG (SEQ ID NO: 3);
the designed primer is sent to Wuhan engine biotechnology limited company for synthesis.
1.2 cloning of Termite Plumbaria Furcata Cry2 Gene sequence
Using the above-described SEQ ID NO: 2-3 specific primers are amplified to obtain a termite prototheca fuliginea Cry2 gene sequence.
And (3) PCR reaction system: mu.L of gold medal Mix, 2. mu.L of forward and reverse primers (10. mu.M) each, and 1. mu.L of RACE template. PCR reaction procedure: pre-denaturation at 98 ℃ for 3 min; denaturation at 98 ℃ for 10sec, annealing at 58 ℃ for 15sec, renaturation extension at 72 ℃ for 20sec, 38 cycles; extension at 72 ℃ for 5 min. And detecting by 1% agarose gel electrophoresis.
Use kit
The Gel Extraction Kit recovered the PCR product. Introducing the recovered DNA fragment into a pMD18-T vector through T-A cloning to construct a recombinant vector; meanwhile, the recombinant vector is transferred into Trans-T1 competent cells and inoculated on an LB solid culture medium containing the benzyl resistance for culture, and then white single colonies are picked and inoculated into an LB liquid culture medium containing the benzyl resistance for continuous culture. And (3) sending the bacterial liquid containing the detected target band to Wuhan Pongzhike biotechnology limited company for sequencing, comparing the sequencing result with an NCBI database to obtain a complete sequence of the gene, wherein the nucleotide length is 2,160bp, and the nucleotide sequence is SEQ ID NO:1, or a fragment thereof.
Example 2 cloning of Termite Black Sclerotium Cry2 Gene sequence
2.1 design of specific primers for Cry2 Gene amplification
Searching is carried out from a transcriptome database of the odontotermes formosanus, and then sequence alignment is carried out by using NCBI Nucleotide-BLAST, so as to determine that 1 termite Cry2 gene fragment is obtained. From the Cry2 gene fragment obtained by the search, the following specific primers were designed online using NCBI Primer-BLAST:
3' Gene-specific primers: CGTGCTCATCGTTTTCAGTATG (SEQ ID NO: 5);
5' Gene-specific primers: GCAGCTCAGAAGCAGATTTCC (SEQ ID NO: 6);
the designed primer is sent to Wuhan engine biotechnology limited company for synthesis.
2.2 cloning of the Termite Black Sclerotium Cry2 Gene sequence
Using the above-described SEQ ID NO: 5-6 specific primer amplification is carried out to obtain the Scopolia formosana Cry2 gene sequence.
And (3) PCR reaction system: mu.L of gold medal Mix, 2. mu.L of forward and reverse primers (10. mu.M) each, and 1. mu.L of RACE template. PCR reaction procedure: pre-denaturation at 98 ℃ for 3 min; denaturation at 98 ℃ for 10sec, annealing at 58 ℃ for 15sec, renaturation extension at 72 ℃ for 20sec, 38 cycles; extension at 72 ℃ for 5 min. And detecting by 1% agarose gel electrophoresis.
Use kit
The Gel Extraction Kit recovered the PCR product. Introducing the recovered DNA fragment into a pMD18-T vector through T-A cloning to construct a recombinant vector; meanwhile, the recombinant vector is transferred into Trans-T1 competent cells and inoculated on an LB solid culture medium containing the benzyl resistance for culture, and then white single colonies are picked and inoculated into an LB liquid culture medium containing the benzyl resistance for continuous culture. And (3) sending the bacterial liquid containing the detected target band to Wuhan Pongzhike biotechnology limited company for sequencing, comparing the sequencing result with an NCBI database to obtain a complete sequence of the gene, wherein the nucleotide length is 1,913bp, and the nucleotide sequence is SEQ ID NO: 4, or a sequence shown in the figure.
Example 3 Synthesis of dsRNA-1 of Termite species of Black wing Cry2 Gene
3.1 primers required for synthesizing dsRNA-1 of Termite species of Black wing Cry2 Gene
Nucleotide sequence based on the termite Cry2 gene of black wing is SEQ ID NO:1, respectively designing an upstream primer 5 '-GGATCCTAATACGACTCACTATA-GGGTCGCCCTAAAA TGACACCTC-3' (SEQ ID NO:8) and a downstream primer 5 '-ATCCTAATACGACTCACTATAGGGCACCACGGGTAAGAAAG-CAT-3' (SEQ ID NO:9) both containing a T7 promoter (GGATCCTAATACGACTCACTATAGGG (SEQ ID NO: 7)), and sending the designed primers to Wuhan Pongzi biotechnology limited company for synthesis.
3.2 preparation of templates for dsRNA-1 Synthesis of Cry2 Gene
Primers required for dsRNA-1 synthesis, both containing the T7 promoter, were combined with a plasmid containing the Cry2 gene for PCR amplification.
And (3) PCR reaction system: mu.L of gold medal Mix, 2. mu.L of forward and reverse primers (10. mu.M) each, and 1. mu.L of cDNA template. PCR reaction procedure: pre-denaturation at 98 ℃ for 3 min; denaturation at 98 ℃ for 10sec, annealing at 60 ℃ for 15sec, renaturation extension at 72 ℃ for 10sec, 38 cycles; extension at 72 ℃ for 5 min. Obtaining a DNA fragment with the length of 398bp, wherein the nucleotide sequence is SEQ ID NO: 10 (both ends contain the T7 promoter). The PCR product was purified using phenol/chloroform/isoamyl alcohol (25: 24: 1) as a template for the synthesis of dsRNA-1 of Cry2 gene.
3.3 Synthesis of dsRNA-1 of Cry2 Gene
Preparing a reaction system in an enzyme-free PCR tube by using the synthesized dsRNA-1 template to perform in vitro transcription synthesis on the dsRNA-1, wherein the transcription reaction program comprises the following steps: reacting at 37 ℃ for 4h, adding DNase I, and reacting at 37 ℃ for 30 min. The quality of dsRNA-1 is detected by using 1% agarose gel electrophoresis, the concentration and the purity of dsRNA-1 are measured by using an ultraviolet spectrophotometer, and the dsRNA-1 is stored in an ultra-low temperature refrigerator at minus 80 ℃ for standby.
Example 4 Synthesis of dsRNA-2 of Sclerodonta nigripes Cry2 Gene
4.1 primers required for synthesizing Scopolia melanothorax Schott Cry2 gene dsRNA-2
Nucleotide sequence based on the termite Cry2 gene of black wing is SEQ ID NO: 4, respectively designing an upstream primer 5 '-GGATCCTAATACGACTCACTATAG-GGGAGGTGTCATTTTAGGGC-G-A-3' (SEQ ID NO:11) and a downstream primer 5 '-GGATCCTAATACGACTCACTATAGGGTTCAAGGAATGGGGC-ACTAC-3' (SEQ ID NO:12) both containing a T7 promoter (GGATCCTAATACGACTCACTATAGGG (SEQ ID NO: 7)), and sending the designed primers to Wuhan Pongzi biotechnology limited company for synthesis.
4.2 preparation of templates for dsRNA-2 Synthesis of Cry2 Gene
Primers required for dsRNA-2 synthesis, both containing the T7 promoter, were combined with a plasmid containing the Cry2 gene for PCR amplification.
And (3) PCR reaction system: mu.L of gold medal Mix, 2. mu.L of forward and reverse primers (10. mu.M) each, and 1. mu.L of cDNA template. PCR reaction procedure: pre-denaturation at 98 ℃ for 3 min; denaturation at 98 ℃ for 10sec, annealing at 60 ℃ for 15sec, renaturation extension at 72 ℃ for 10sec, 38 cycles; extension at 72 ℃ for 5 min. Obtaining a DNA fragment with the length of 463bp, wherein the nucleotide sequence is SEQ ID NO: 13 (both ends contain the T7 promoter). The PCR product was purified using phenol/chloroform/isoamyl alcohol (25: 24: 1) as a template for the synthesis of dsRNA-2 of Cry2 gene.
4.3 Synthesis of dsRNA-2 of Cry2 Gene
Preparing a reaction system in an enzyme-free PCR tube by using the synthesized dsRNA-2 template to perform in vitro transcription synthesis on the dsRNA-2, wherein the transcription reaction program comprises the following steps: reacting at 37 ℃ for 4h, adding DNase I, and reacting at 37 ℃ for 30 min. The quality of dsRNA-2 is detected by using 1% agarose gel electrophoresis, the concentration and purity of dsRNA-2 are measured by using an ultraviolet spectrophotometer, and the dsRNA-2 is stored in an ultra-low temperature refrigerator at minus 80 ℃ for standby.
Example 5 detection of interference Effect of dsRNA of Termite Cooperia punctata and Termite Black Sclerotium Cry2 genes
5.1 introduction of dsRNA of Termite Cry2 Gene
Respectively selecting the white ant and white ant with consistent size and good growth condition for dsRNA injection, wherein the white ant is injected with dsRNA-1, and the white ant is injected with dsRNA-2. After cryoanesthesia on ice, injection is carried out at the membrane between the 1 st and the 2 nd thoracic nodes on the side of the chest of the worker ant. Mu.g of dsRNA was introduced into termites by microinjection. The termites after injection were housed in a petri dish with a diameter of 9 cm. Termites injected with dsRNA-1 or dsRNA-2 were used as the treatment group, and termites injected with an equal amount of dsGFP were used as the control group.
5.2 detecting the mRNA expression quantity of termite Cry2 gene segment
After 3d of dsRNA injection, 3 good termites were randomly selected from the treated group and the control group respectively as a biological repeat to detect the expression level of Cry2 gene mRNA.
Total RNA was extracted by the RNAioso Plus (Trizol) method. The extracted RNA was reverse transcribed with reference to the PrimeScript RT reagent Kit with gDNA Eraser (Perfect Real Time) Kit instructions. Subsequently, the mRNA expression amounts of the target gene Cry2 and the reference genes beta-actin and NADH are detected by using a Real-time PCR method, so that the interference efficiency of the Cry2 gene is analyzed. Each treatment set 9 biological replicates.
The results show that the mRNA expression data do not fit a normal distribution. Thus, using Wilcoxon test to test dsRNA injected termites, a significant decrease in Cry2 gene expression was found in termites (as shown in fig. 1A-B).
Example 6 Effect of dsRNA of Cry2 Gene on the magnetic orientation behavior of Termite
6.1 magnetic orientation behavior testing device for termite design
Termite magnetic orientation behavior test in an open circular behavior test device (diameter 30cm, height 1cm) with a moist filter paper (diameter 30cm) laid on the bottom, in order to prevent termites from not moving in the test device, moist filter paper (diameter 2cm) containing 7.5% glucose was placed in the test device in four directions (0 °, 90 °, 180 ° and 270 ° clockwise with respect to the direction of the geomagnetic field). The termite trajectories were recorded with infrared cameras (acA1920-40gc, germany). The video was subjected to quantitative analysis using the motion trajectory tracking system EthoVision-XT (Noldus Information Technology, the netherlands).
6.2 testing of magnetic Directional behavior of Termite
At the beginning of the experiment, test termites were placed in the behavior testing apparatus. Test termites were allowed to acclimate to the test environment for 1h before shooting and then tested in the test apparatus for 4 min. The termite trajectories were recorded with an infrared camera (acA1920-40gc, germany) and captured at a rate of 25 frames/second. Termite mean orientation was quantified on video using the motion trajectory tracking system EthoVision-XT (Noldus Information Technology, the netherlands). Termites injected with dsCry2 were treated and termites injected with an equal amount of dsGFP were control. Each treatment was repeated more than 30 times.
The results showed that the directional preference of two termites injected with dsCry2 disappeared (black-wing odontotermes formosanus: r ═ 0.124, p ═ 0.563; black-thorny termites: r ═ 0.09, p ═ 0.706 as shown in fig. 2A and 2C), but two termites injected with dsGFP had significant directional preference (black-wing odontotermes formosanus: r ═ 0.294, p ═ 0.021; black-thorny termites: r ═ 0.31, p ═ 0.011;). In addition, the termite injected with dsCry2 had a significantly higher turning angle of motion than the termite injected with dsGFP (black wing odontotermes formosanus: Z-2.43, df-81, p < 0.05; black thorny termites: Z-3.15, df-88, p <0.05 as shown in fig. 3A-B).
As can be seen from the results of example 6, termites injected with dsCry2 not only disappeared the magnetic orientation behavior, but also the turning angle of motion was significantly increased. Thus, the interference of the foraging orientation and the homing capability of the termites after the Cry2 gene is silenced by the RNAi technology is shown.
The above-described embodiments are merely illustrative of the preferred embodiments of the present invention, and do not limit the scope of the present invention, and various modifications and improvements of the technical solutions of the present invention can be made by those skilled in the art without departing from the spirit of the present invention, and the technical solutions of the present invention are within the scope of the present invention defined by the claims.
Sequence listing
<110> university of agriculture in Huazhong
<120> dsRNA for preventing and treating termites and application thereof
<160> 13
<170> SIPOSequenceListing 1.0
<210> 1
<211> 2160
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
cgttgcacgc ggtgtgtaat gtgaaggtgt cgtgtacaga acagatgtaa agaaatttgg 60
cgtagaagat ttccattcgt tcgtgaactt tgtatttctc aggtgttcat cattttcagg 120
atgaaatgtg tgtcaagggc agttaatcat cagtgtcctg gctaaatcat tatgaacgcg 180
ggaagcagtg aaaagcacac cgtacattgg tttagaaagg gtcttcgttt acatgacaat 240
ccaagtttac gtgaaggatt gaagtcttct acgacattcc gttgtgtgtt cattttggac 300
ccttggtttg ctggctcatc aaatgtagga attaacaaat ggcgattcct gctacagtgt 360
ctggaagatt tggatcaaaa tttacgtaaa cttaactctc gtttatttgt aattcgtgga 420
caaccagcag atgctcttcc aaaactgttt aaggaatggg gcactacaaa cctcacattc 480
gaagaggatc ccgaaccctt tggatgggtc cgtgaccaga atattacggc catgtgcaaa 540
gaacttggca tcactgttat atccagagtt tctcacacct tgtaccagct cgaaactatc 600
atcaagaaga atggtggaaa agcccctctg acttatcatc aattccagac aatagtggca 660
tccatggaaa ccccaccacc aacagaacca actatcaacc aacatttcct taatggtacc 720
tacactccca ttggagaaga tcatgatgag aaatatggtg ttccaacact agaagaacta 780
ggttttgata cagatggtct tcttccacca gtatggaaag gaggggaatc ggaggcattg 840
gcgagactgg agaggcatct tgagcgaaaa gcttgggttg catcatttgg tcgccctaaa 900
atgacacctc agtcattact tgctagccaa acaggtctga gtccatatct aaggtttggt 960
tgcctttcta caagattatt ctactatcaa ctgacggatt tatataagaa gatcaagaag 1020
gcatatcccc ccctctctct ccatggtcaa cttctctggc gtgagttctt ctattgtgca 1080
gcaacaaaga atccaaactt tgacaaaatg agtggaaatc ccatttgtgt tcagattcca 1140
tgggacagga atgctgaagc tcttgcaaag tgggcaaatg gccaaactgg gtttccatgg 1200
attgatgcca taatgacaca acttcgacag gagggatgga ttcatcacat agcacggcat 1260
gctgttgcat gctttcttac ccgtggtgat ctctggatct cttgggaaga aggaatgaag 1320
gtgtttgaag aacttctgct ggatgctgat tggtctgtga atgctggcat gtggatgtgg 1380
ctgtcatgtt catctttctt tcagcaattt tttcattgct attgtccagt gcgctttgga 1440
cgcaaggctg accccaatgg agattacatt cgaaagtatc taccagtcct caagaacttc 1500
ccaacacgtt acatccatga accttggaat gcacctgaag ctgttcagaa agcagcaaaa 1560
tgcatcattg gaaaggagta ttctcttcct atggtaaacc atgcagttgc cagcagaatc 1620
aacattgagc gcatgaagca ggtttatcag cagctcagca aatacagagg accaggtttg 1680
ttagctactg tccctacaag ccagtcacgg acatcaaaca ctttgaaccc tacattagga 1740
cagaaagatt tccagaaatc ttcagaaact aagtgggagg ccttgcctgg tgttgatatt 1800
aatggatatt ctctagtaat ctgtgatgaa gattttaaga ctggaattca gtcctactgt 1860
tacaaatcac aaaataagga agaatatgaa taatgagact gatcaaaaag tgactgttga 1920
agtgaacagt atgcacacag tctgttattc aaatgagcaa tgctgtatga agcacaggat 1980
agtgaaaaat ggaaatctgc ttctgagctg cacattatgc atgtaggtct cattttaaac 2040
tatttcgttt tgcacgattt cactttaatg tgactaaaat ttacacaact ttttgaattt 2100
atgggatagt ttctgatgta atacagtgtg gcatacacga tccatggccg cttttgcctt 2160
<210> 2
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
tcgccctaaa atgacacctc 20
<210> 3
<211> 21
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
cattatgaac gcgggaagca g 21
<210> 4
<211> 1913
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
cgtgctcatc gttttcagta tgaaatgtgt gtcaagggca gttaatcatc agtttcctgg 60
ctaagtcatt atgaacgcgg aaaatagtga aaagcatacc gtacattggc ttaggaaggg 120
acttcgttta catgacaatc caagtttacg tgaaggactg aactctgcta cgacattccg 180
ttgtgtgttc attttggacc cctggtttgc tggctcatca aatgtaggaa ttaacaaatg 240
gcgattcctc ctacaatgtc tggaagatct ggatcaaaat ttacgcaaac taaactctcg 300
cttatttgtg attcgtggac aaccagcaga tgctcttcca aaactattca aggaatgggg 360
cactacaaac ctcacattcg aagaggatcc cgaacccttt ggatgggtcc gtgaccagaa 420
tattgcggcc atgtgcaaag aacttggcat cactgttata tccagagttt ctcacacctt 480
gtaccagctc gaaactatca tcaagaagaa tggtggaaaa gcccctctga cttatcatca 540
attccagaca atagtggcat ccatggaaac cccaccacca gcagaaccaa ctatcaacca 600
acatttcctt aatggtacct acactcccat tggagaagat catgatgaga aatatggtgt 660
tccaacacta gaagaactag gttttgatac agatggtctt cttccaccag tatggaaagg 720
aggggaatcg gaggcattgg cgagactgga gaggcatctt gagcgaaaag cttgggttgc 780
atcatttggt cgccctaaaa tgacacctca gtcattactt gctagccaaa caggtctgag 840
tccatatcta aggtttggtt gcctttctac aagattattc tactatcaac tgacggattt 900
atataagaag atcaagaagg catatccccc cctctctctc catggtcaac ttctctggcg 960
tgagttcttc tattgtgcag caacaaagaa tccaaacttt gacaaaatga gtggaaatcc 1020
catttgtgtt cagattccat gggacaggaa tgctgaagct cttgcaaagt gggcaaatgg 1080
ccaaactggg tttccatgga ttgatgccat aatgacacaa cttcgacagg agggatggat 1140
tcatcacata gcacggcatg ctgttgcatg ctttcttacc cgtggtgatc tctggatctc 1200
ttgggaagaa ggaatgaagg tgtttgaaga acttctgctg gatgctgatt ggtctgtgaa 1260
tgctggcatg tggatgtggc tgtcatgttc atctttcttt cagcagtttt ttcattgcta 1320
ttgtccagtg cgctctggac gcaaggctga ccccaacgga gattacattc gaaagtatct 1380
gccagtcctc aggaacttcc caacacgtta catccatgaa ccatggaatg cacctgaagc 1440
tgttcaaaaa gcagcaaaat gcatcattgg aaaggagtat tctcttccta tggtaaacca 1500
tgcagttgcc agcagaatca acattgagcg gatgaagcag gtttatcagc aactgagcaa 1560
atacagagga ccaggtttgt tagctactgt ccctacaagc cagttacaga catccaacac 1620
tttgaaccct acattagtac agaaagattt ccagaaatcc ccatcatcag aaactaagtg 1680
ggaaaccttg tgtggtgatg atattaatgg atattctcta ataatctgtg atgatttcaa 1740
gactggaatt caatcctatt gttacaaatc acaaaaaaag gaatatgagt aatggggctg 1800
atcaacaagt gactgctgaa gtgaacagta tgcacacaat ctgttctgca aatgagcagt 1860
gctgtatgtg gcacagggta atgaaaaatg gaaatctgct tctgagctgc aca 1913
<210> 5
<211> 22
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
cgtgctcatc gttttcagta tg 22
<210> 6
<211> 21
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
gcagctcaga agcagatttc c 21
<210> 7
<211> 26
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
ggatcctaat acgactcact ataggg 26
<210> 8
<211> 46
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 8
ggatcctaat acgactcact atagggtcgc cctaaaatga cacctc 46
<210> 9
<211> 46
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 9
ggatcctaat acgactcact atagggcacc acgggtaaga aagcat 46
<210> 10
<211> 398
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 10
tcgccctaaa atgacacctc agtcattact tgctagccaa acaggtctga gtccatatct 60
aaggtttggt tgcctttcta caagattatt ctactatcaa ctgacggatt tatataagaa 120
gatcaagaag gcatatcccc ccctctctct ccatggtcaa cttctctggc gtgagttctt 180
ctattgtgca gcaacaaaga atccaaactt tgacaaaatg agtggaaatc ccatttgtgt 240
tcagattcca tgggacagga atgctgaagc tcttgcaaag tgggcaaatg gccaaactgg 300
gtttccatgg attgatgcca taatgacaca acttcgacag gagggatgga ttcatcacat 360
agcacggcat gctgttgcat gctttcttac ccgtggtg 398
<210> 11
<211> 46
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 11
ggatcctaat acgactcact ataggggagg tgtcatttta gggcga 46
<210> 12
<211> 46
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 12
ggatcctaat acgactcact atagggttca aggaatgggg cactac 46
<210> 13
<211> 463
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 13
ttcaaggaat ggggcactac aaacctcaca ttcgaagagg atcccgaacc ctttggatgg 60
gtccgtgacc agaatattgc ggccatgtgc aaagaacttg gcatcactgt tatatccaga 120
gtttctcaca ccttgtacca gctcgaaact atcatcaaga agaatggtgg aaaagcccct 180
ctgacttatc atcaattcca gacaatagtg gcatccatgg aaaccccacc accagcagaa 240
ccaactatca accaacattt ccttaatggt acctacactc ccattggaga agatcatgat 300
gagaaatatg gtgttccaac actagaagaa ctaggttttg atacagatgg tcttcttcca 360
ccagtatgga aaggagggga atcggaggca ttggcgagac tggagaggca tcttgagcga 420
aaagcttggg ttgcatcatt tggtcgccct aaaatgacac ctc 463
Claims (4)
1. dsRNA for controlling termites, which is dsRNA-1 or dsRNA-2;
wherein the dsRNA-1 consists of a sequence as shown in SEQ ID NO: 10 is transcribed; the dsRNA-2 consists of a sequence shown as SEQ ID NO: 13 is transcribed.
2. A template DNA for synthesizing the dsRNA-1 or dsRNA-2 of claim 1, wherein the nucleotide sequence of the template DNA of dsRNA-1 is as shown in SEQ ID NO: 10 is shown in the figure; the nucleotide sequence of the template DNA of the dsRNA-2 is shown as SEQ ID NO: shown at 13.
3. Use of the dsRNA of claim 1 or the template DNA of claim 2, comprising any one of:
(1) use of the dsRNA of claim 1 or the template DNA of claim 2 for termite control;
(2) use of the dsRNA of claim 1 or the template DNA of claim 2 in the preparation of a termite control product;
(3) use of the dsRNA of claim 1 or the template DNA of claim 2 to interfere with termite magnetic orientation behavior;
(4) use of the dsRNA of claim 1 or the template DNA of claim 2 in the preparation of a product that interferes with the magnetic directional behavior of termites;
(5) use of the dsRNA of claim 1 or the template DNA of claim 2 to interfere with termite foraging orientation and homing ability;
(6) use of the dsRNA of claim 1 or the template DNA of claim 2 in the preparation of a product that interferes with termite foraging orientation and homing ability;
(7) use of the dsRNA of claim 1 or the template DNA of claim 2 for reducing termite motion turns;
(8) use of the dsRNA of claim 1 or the template DNA of claim 2 in the preparation of a termite motion corner reducing product.
4. A method of termite control, interfering with the magnetic directional behavior, interfering with the foraging orientation and homing capacity, or reducing the turning angle of termite movement, said method comprising: introducing the dsRNA of claim 1 into a termite body.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110538502.XA CN113234724B (en) | 2021-05-18 | 2021-05-18 | dsRNA (double-stranded ribonucleic acid) for preventing and treating termites and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110538502.XA CN113234724B (en) | 2021-05-18 | 2021-05-18 | dsRNA (double-stranded ribonucleic acid) for preventing and treating termites and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113234724A CN113234724A (en) | 2021-08-10 |
| CN113234724B true CN113234724B (en) | 2022-04-05 |
Family
ID=77135062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110538502.XA Active CN113234724B (en) | 2021-05-18 | 2021-05-18 | dsRNA (double-stranded ribonucleic acid) for preventing and treating termites and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113234724B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115927349B (en) * | 2021-09-22 | 2024-02-20 | 南京林业大学 | Subterranean termite gram negative bacteria recognition protein GNBP2 gene and application thereof |
| CN115896116A (en) * | 2021-09-22 | 2023-04-04 | 南京林业大学 | Termite formosana gram-negative bacteria recognition protein GNBP1 gene and application thereof |
| CN116024219B (en) * | 2021-10-27 | 2024-08-20 | 南京林业大学 | Subterranean termite antibacterial peptide Oftermicin gene and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105980566A (en) * | 2012-07-26 | 2016-09-28 | 先锋国际良种公司 | Novel Insecticidal Protein and Its Use |
| CN111748533A (en) * | 2020-07-03 | 2020-10-09 | 华中农业大学 | Termite SelT gene and application of dsRNA (double-stranded ribonucleic acid) thereof in combination with metarhizium anisopliae in termite control |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2637363C (en) * | 2006-02-13 | 2016-04-05 | Monsanto Technology Llc | Selecting and stabilizing dsrna constructs |
-
2021
- 2021-05-18 CN CN202110538502.XA patent/CN113234724B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105980566A (en) * | 2012-07-26 | 2016-09-28 | 先锋国际良种公司 | Novel Insecticidal Protein and Its Use |
| CN111748533A (en) * | 2020-07-03 | 2020-10-09 | 华中农业大学 | Termite SelT gene and application of dsRNA (double-stranded ribonucleic acid) thereof in combination with metarhizium anisopliae in termite control |
Non-Patent Citations (2)
| Title |
|---|
| In addition to cryptochrome 2, magnetic particles with olfactory co-receptor are important for magnetic orientation in termites;Yongyong Gao等;《COMMUNICATIONS BIOLOGY》;20210923;1-12 * |
| 隐花色素CRY2基因片段克隆及RNAi植物表达载体的构建;周波等;《分子植物育种》;20081215(第06期);160-164 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113234724A (en) | 2021-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113234724B (en) | dsRNA (double-stranded ribonucleic acid) for preventing and treating termites and application thereof | |
| CN104610440B (en) | Applications of the ABC transporter gene ABCH1 and its specific dsRNA in diamondback moth preventing and treating and Bt resistance managements | |
| CN114591964B (en) | Equisetum arvense death gene HvSrp54k and application thereof | |
| CN109666675B (en) | Nilaparvata lugens NlAtg3 gene, encoding protein and application thereof | |
| CN106084024B (en) | The preparation and application of litopenaeus vannamei antibacterial peptide-CrustinA gene and its recombinant protein | |
| CN116732042B (en) | Bemisia tabaci Gawky gene and application thereof in biological control of Bemisia tabaci | |
| CN117230065A (en) | dsRNA of aphid FKBP12 gene, and preparation method and application thereof | |
| KR102226556B1 (en) | Composition for controlling thrips comprising TLR6 or COPE protein inhibitors as effective component and uses thereof | |
| CN103255154B (en) | Oxygenase gene caceO as well as coded protein and application of oxygenase gene | |
| CN115896118B (en) | Brown planthopper salivary protein NlG gene and protein for inducing plant to generate resistance and application thereof | |
| CN103275202A (en) | Disease resistance-related protein RCR1 derived from wheat, related biomaterials thereof, and application for same | |
| CN110129327B (en) | Migratory locust pore canal formation related geneLmsnarAnd application of dsRNA thereof in locusta migratoria control | |
| CN107287169A (en) | A kind of eggplant cytochrome P450 gene StCYP84A and its preparation method and application | |
| CN115927349B (en) | Subterranean termite gram negative bacteria recognition protein GNBP2 gene and application thereof | |
| CN116024219B (en) | Subterranean termite antibacterial peptide Oftermicin gene and application thereof | |
| CN115029357B (en) | Insect m 6 dsRNA of A methylation reading protein elF3-S6 gene and application thereof | |
| CN115011577B (en) | Insect m 6 A-methylation transferase METTL3 gene fragment, dsRNA thereof and application thereof | |
| CN112029772B (en) | Gustavus gene and application thereof, dsRNA synthesized by Gustavus gene and preparation method and application of dsRNA | |
| CN116445499B (en) | DsABCG gene, protein coded by DsABCG gene, recombinant expression vector, method and application | |
| CN115925856B (en) | Brown planthopper heat shock transcription factor NlHsf, cDNA and application | |
| CN114540362B (en) | Equisetum arvense death gene HvABCH1 and application thereof | |
| CN110563828B (en) | Chilo suppressalis male specificity lethal associated protein MSL3, coding gene, dsRNA interference sequence and application thereof | |
| CN115896117A (en) | Termite formosana gram-negative bacterium recognition protein GNBP3 gene and application thereof | |
| CN118086290A (en) | Subterranean termite OfArgonaute gene and application thereof | |
| CN115896116A (en) | Termite formosana gram-negative bacteria recognition protein GNBP1 gene and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |